Literature DB >> 22441456

Heterotopic bone formation following anterior cruciate ligament reconstruction with BPTB autograft.

Mehmet Erdil1, Mehmet Aşık, Cengiz Sen, Gökhan Polat.   

Abstract

In this study, we present a 36-year-old male patient who developed heterotopic ossification after anterior cruciate ligament (ACL) reconstruction performed using bone-patellar tendon-bone autograft harvested from the 1/3 middle part of the patellar tendon. This ossified part, which restricted range of motion of the affected knee, was excised surgically 1 year after diagnosis. Physical examination, conducted 36 months later, revealed the achievement of full range of motion without any complaints or recurrences. Heterotopic ossification following ACL reconstruction is a very rare complication, which should be removed with open surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22441456     DOI: 10.3944/aott.2012.2529

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  3 in total

1.  No Difference in Outcome of Anterior Cruciate Ligament Reconstruction with "Bone-patellar Tendon-bone versus Semitendinosus-gracilis Graft with Preserved Insertion": A Randomized Clinical Trial.

Authors:  Ravi Gupta; Anil Kapoor; Ashwani Soni; Sourabh Khatri; Gladson David Masih; Mukta Raghav
Journal:  Indian J Orthop       Date:  2020-04-28       Impact factor: 1.251

2.  Patellar tendon ossification after anterior cruciate ligament reconstruction using bone--patellar tendon--bone autograft.

Authors:  Gianluca Camillieri; Vincenzo Di Sanzo; Matteo Ferretti; Cosma Calderaro; Vittorio Calvisi
Journal:  BMC Musculoskelet Disord       Date:  2013-05-10       Impact factor: 2.362

3.  No Difference in Outcome of Anterior Cruciate Ligament Reconstruction with "Bone-patellar Tendon-bone versus Semitendinosus-gracilis Graft with Preserved Insertion:" A Randomized Clinical Trial.

Authors:  Ravi Gupta; Anil Kapoor; Ashwani Soni; Sourabh Khatri; Gladson David Masih; Mukta Raghav
Journal:  Indian J Orthop       Date:  2019 Nov-Dec       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.